It has several newer products on the market driving growth, including respiratory syncytial virus vaccine Abrysvo. The company's acquisitions in recent years are paying off, with drugs including ...

Chemical engineers are problem solvers - they bring new medicines to market, develop alternative fuels, keep food manufacturing safe, and create new manufacturing materials. They move small-scale ...

Recent advances have resulted in clinical options to offer high-risk patients: AREXY ®, mRESVIA ®, and ABRYSVO ® for people ages 60 and older; ABRYSVO ® for pregnant women at 32 to 36 weeks gestation; ...

Pfizer is seeing a strong uptick in Vyndaqel and Abrysvo and a continued growth in Eliquis has aided the overall sales growth lately. Vyndaqel sales were up 66% y-o-y to $3.9 billion for the nine ...

Kirillov was the commander of Russia’s Radiation, Chemical and Biological Protection Forces, and is thought to be the most senior military figure assassinated in Russia since the country invaded ...

Pfizer’s PFE RSV vaccine, Abrysvo, was launched to help protect older adults as well as infants through maternal immunization in the United States as well as in the EU in 2023. PFE’s Abrysvo ...

Now, a team has found a molecule that could provide caloric restriction in a pill ― at least for flies and worms. There is no evidence yet that taking lithocholic acid would have the same effect ...

Pfizer is also at the beginning of the critical—and competitive—launch of the respiratory syncytial virus (RSV) vaccine Abrysvo. A recent CDC restriction on RSV vaccinations already showed ...

Beyfortus can be used in infants who are entering their first or second RSV season, while Pfizer’s vaccine Abrysvo can be given to pregnant women to pass on passive immunity to their newborns.

Pfizer's internal research and development (R&D) is also paying off, with respiratory syncytial virus vaccine Abrysvo's 53% market share a case in point. Meanwhile, Pfizer offers one of the most ...

There are currently several ways to protect children from RSV. Beyfortus can be used in infants who are entering their first or second RSV season, while Pfizer’s vaccine Abrysvo can be given to ...